Here's how the brokerages interpret the results:
Target price: Rs 142 | Reco: Buy
Revenue of Rs 1,020 crore for Q1FY21 was 15 per cent ahead of our estimates. EBITDA of Rs 480 crore beat our estimate by 55 per cent. However, IRB reported loss of Rs 30.13 crore, marginally behind our estimate on account of higher than expected finance cost, taxes and losses of JVs/associates. Basis management commentary, APAT would have been at around Rs 54 crore, if the company had recognized compensation income, as per the agreement signed with the clients.
Consolidated gross debt stood at Rs 14,350 crore. With cash balance of Rs 2,100 crore, net D/E stood at 1.75x. With completion of transaction with GIC, moratorium on loan repayment and interest payment, and fund raising of ~Rs 15bn at parent level, IRB has considerably shored up its liquidity. IRB will invest Rs 550 crore in the nine SPVs transferred to private InvIT.